|Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an “intestinal” pathway of carcinogenesis in the pancreas|
NV Adsay, K Merati, O Basturk, C Iacobuzio-Donahue, E Levi, JD Cheng, ...
The American journal of surgical pathology 28 (7), 839-848, 2004
|Curcumin synergizes with resveratrol to inhibit colon cancer|
APN Majumdar, S Banerjee, J Nautiyal, BB Patel, V Patel, J Du, Y Yu, ...
Nutrition and cancer 61 (4), 544-553, 2009
|T-cell clonality in pityriasis lichenoides et varioliformis acuta: a heteroduplex analysis of 20 cases|
O Dereure, E Levi, ME Kadin
Archives of dermatology 136 (12), 1483-1486, 2000
|A deletion in the gene for transforming growth factor β type I receptor abolishes growth regulation by transforming growth factor β in a cutaneous T-cell lymphoma|
WP Schiemann, WM Pfeifer, E Levi, ME Kadin, HF Lodish
Blood, The Journal of the American Society of Hematology 94 (8), 2854-2861, 1999
|Differential tissue distribution of tryptophan hydroxylase isoforms 1 and 2 as revealed with monospecific antibodies|
SA Sakowski, TJ Geddes, DM Thomas, E Levi, JS Hatfield, DM Kuhn
Brain research 1085 (1), 11-18, 2006
|Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF|
S Roy, E Levi, APN Majumdar, FH Sarkar
Journal of hematology & oncology 5 (1), 58, 2012
|MUC1 and MUC2 in pancreatic neoplasia|
E Levi, DS Klimstra, NV Adsay, A Andea, O Basturk
Journal of clinical pathology 57 (5), 456-462, 2004
|Folic acid supplementation inhibits recurrence of colorectal adenomas: a randomized chemoprevention trial|
R Jaszewski, S Misra, M Tobi, N Ullah, JA Naumoff, O Kucuk, E Levi, ...
World journal of gastroenterology: WJG 14 (28), 4492, 2008
|Metformin: a potential therapeutic agent for recurrent colon cancer|
P Nangia-Makker, Y Yu, A Vasudevan, L Farhana, SG Rajendra, E Levi, ...
PloS one 9 (1), e84369, 2014
|Infrequent Fas mutations but no Bax or p53 mutations in early mycosis fungoides: a possible mechanism for the accumulation of malignant T lymphocytes in the skin|
O Dereure, E Levi, ME Kadin, EC Vonderheid
Journal of investigative dermatology 118 (6), 949-956, 2002
|miR-21 and miR-145 cooperation in regulation of colon cancer stem cells|
Y Yu, P Nangia-Makker, L Farhana, SG Rajendra, E Levi, APN Majumdar
Molecular cancer 14 (1), 1-11, 2015
|A proposal for a new and more practical grading scheme for pancreatic ductal adenocarcinoma|
NV Adsay, O Basturk, M Bonnett, N Kilinc, AA Andea, J Feng, M Che, ...
The American journal of surgical pathology 29 (6), 724-733, 2005
|Cell cycle-and apoptosis-regulatory protein-1 is involved in apoptosis signaling by epidermal growth factor receptor|
AK Rishi, L Zhang, Y Yu, Y Jiang, J Nautiyal, A Wali, JA Fontana, E Levi, ...
Journal of Biological Chemistry 281 (19), 13188-13198, 2006
|Mechanisms of curcumin-and EGF-receptor related protein (ERRP)-dependent growth inhibition of colon cancer cells|
S Reddy, AK Rishi, H Xu, E Levi, FH Sarkar, APN Majumdar
Nutrition and cancer 55 (2), 185-194, 2006
|Fascin expression in CD30‐positive cutaneous lymphoproliferative disorders|
W Kempf, E Levi, J Kamarashev, H Kutzner, W Pfeifer, ...
Journal of cutaneous pathology 29 (5), 295-300, 2002
|Age-related increase in colorectal cancer stem cells in macroscopically normal mucosa of patients with adenomas: a risk factor for colon cancer|
BB Patel, Y Yu, J Du, E Levi, PA Phillip, APN Majumdar
Biochemical and biophysical research communications 378 (3), 344-347, 2009
|A murine xenograft model for human CD30+ anaplastic large cell lymphoma: successful growth inhibition with an anti-CD30 antibody (HeFi-1)|
W Pfeifer, E Levi, T Petrogiannis-Haliotis, L Lehmann, Z Wang, ME Kadin
The American journal of pathology 155 (4), 1353-1359, 1999
|Transactivator of transcription–tagged cell cycle and apoptosis regulatory protein-1 peptides suppress the growth of human breast cancer cells in vitro and in vivo|
L Zhang, E Levi, P Majumder, Y Yu, A Aboukameel, J Du, H Xu, ...
Molecular cancer therapeutics 6 (5), 1661-1672, 2007
|The role of hemorheologic factors in the coronary circulation|
OK Başkurt, E Levi, S Çağlayan, N Dikmenoğlu, O Ücer, R Güner, ...
Clinical Hemorheology and Microcirculation 11 (1-2), 121-127, 1991
|Distinct effects of CD30 and Fas signaling in cutaneous anaplastic lymphomas: a possible mechanism for disease progression|
E Levi, Z Wang, T Petrogiannis-Haliotis, WM Pfeifer, W Kempf, R Drews, ...
Journal of investigative dermatology 115 (6), 1034-1040, 2000